MINOCYCLINE HYDROCHLORIDE capsule

国: アメリカ合衆国

言語: 英語

ソース: NLM (National Library of Medicine)

有効成分:

MINOCYCLINE HYDROCHLORIDE (UNII: 0020414E5U) (MINOCYCLINE - UNII:FYY3R43WGO)

から入手可能:

Physicians Total Care, Inc.

INN（国際名）:

MINOCYCLINE HYDROCHLORIDE

構図:

MINOCYCLINE 50 mg

投与経路:

ORAL

処方タイプ:

PRESCRIPTION DRUG

適応症:

Minocycline hydrochloride capsules, USP are indicated in the treatment of the following infections due to susceptible strains of the designated microorganisms: Rocky Mountain spotted fever, typhus fever and the typhus group, Q fever, rickettsialpox and tick fevers caused by rickettsiae. Respiratory tract infections caused by Mycoplasma pneumoniae . Lymphogranuloma venereum caused by Chlamydia trachomatis . Psittacosis (Ornithosis) due to Chlamydia psittaci . Trachoma caused by Chlamydia trachomatis , although the infectious agent is not always eliminated, as judged by immunofluorescence. Inclusion conjunctivitis caused by Chlamydia trachomatis . Nongonococcal urethritis, endocervical, or rectal infections in adults caused by Ureaplasma urealyticum or Chlamydia trachomatis . Relapsing fever due to Borrelia recurrentis . Chancroid caused by Haemophilus ducreyi . Plague due to Yersinia pestis . Tularemia due to Francisella tularensis . Cholera caused by Vibrio cholerae . Campylobacter fetus infections caused by

製品概要:

Minocycline HCl Capsules, USP equivalent to 50 mg minocycline are white to off-white opaque capsules imprinted “RX 694 ” on cap and body in black ink and supplied as follows: NDC 54868-2390-0    Bottles of 60 NDC 54868-2390-1    Bottles of 30 Minocycline HCl Capsules, USP equivalent to 75 mg minocycline are gray opaque capsules imprinted “RX 695 ” on cap and body in black ink and supplied as follows: NDC 54868-5040-0    Bottles of 30 NDC 54868-5040-1    Bottles of 10 NDC 54868-5040-2    Bottles of 60 Minocycline HCl Capsules, USP equivalent to 100 mg* minocycline with a gray opaque cap and white opaque body imprinted “RX 696 ” on cap and body in black ink and supplied as follows: NDC 654868-2391-0   Bottles of 10 NDC 654868-2391-1   Bottles of 60 NDC 654868-2391-2   Bottles of 30 NDC 654868-2391-3   Bottles of 50 NDC 654868-2391-4   Bottles of 100 NDC 654868-2391-5   Bottles of 90 NDC 654868-2391-6   Bottles of 20 NDC 654868-2391-7   Bottles of 180 Store at 20° - 25° C (68° - 77° F) [See USP Controlled Room Temperature]. Protect from light, moisture, and excessive heat. Dispense in a tight, light-resistant containers with child-resistant closure.

認証ステータス:

Abbreviated New Drug Application

製品の特徴

MINOCYCLINE HYDROCHLORIDE- MINOCYCLINE HYDROCHLORIDE CAPSULE
PHYSICIANS TOTAL CARE, INC.
----------
MINOCYCLINE HYDROCHLORIDE CAPSULES, USP
RX ONLY
To reduce the development of drug-resistant bacteria and maintain the
effectiveness of minocycline
hydrochloride capsules, USP and other antibacterial drugs, minocycline
hydrochloride capsules, USP
should be used only to treat or prevent infections that are proven or
strongly suspected to be caused by
bacteria.
DESCRIPTION
Minocycline hydrochloride, USP, is a semisynthetic derivative of
tetracycline, 4,7-Bis
(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-2-
naphthacenecarboxamide monohydrochloride.
Its structural formula is:
C
H N O •HCl M.W. 493.95
Each minocycline hydrochloride capsule, USP for oral administration,
contains the equivalent of 50 mg,
75 mg or 100 mg of minocycline. In addition each capsule contains the
following inactive ingredients:
corn starch and magnesium stearate.
The 50 mg, 75 mg and 100 mg capsule shells contain: gelatin and
titanium dioxide.
The 75 mg and 100 mg capsule shells also contain black iron oxide.
The imprinting ink contains: black iron oxide, potassium hydroxide,
propylene glycol, and shellac.
CLINICAL PHARMACOLOGY
Following a single dose of two minocycline hydrochloride capsules, 100
mg administered to 18 normal
fasting adult volunteers, maximum serum concentrations were attained
in 1 to 4 hours (average 2.1
hours) and ranged from 2.1 to 5.1 mcg/mL (average 3.5 mcg/mL). The
serum half-life in the normal
volunteers ranged from 11.1 to 22.1 hours (average 15.5 hours).
When minocycline hydrochloride capsules were given concomitantly with
a high-fat meal, which
included dairy products, the extent of absorption of minocycline
hydrochloride capsules was unchanged
compared to dosing under fasting conditions. The mean T
was delayed by one hour when
administered with food, compared to dosing under fasting conditions.
Minocycline hydrochloride
capsules may be administered with or without food.
23
27
3
7